Pennsylvania court: “Overall anticompetitive scheme” alleged in Suboxone litigation
A swathe of claims from direct purchasers, end consumers and state attorneys general accusing Indivior of monopolising the market for opioid addiction treatment Suboxone have survived the pharmaceutical company’s motion for summary judgment.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10